Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Lonza Announces to Expand HPAPI Development and Manufacturing Capacity

Lonza announced an expansion of Highly Potent API HPAPI capabilities from development to commercial scale manufacturing including formulation and delivery

Tergus Pharma to Build a New Commercial Manufacturing Facility with Great Point Partners

Tergus Pharma partners with Great Point Partners to build a new commercial manufacturing facility A square feet new expansion will provide comprehensive services from development through manufacturing and will become a Contract Development and Manufacturing Organisation or CDMO

Aldevron Breaks Ground to Build 14-Acre Gene Therapy Manufacturing Campus

Aldevron announces its plans to build acre gene therapy manufacturing campus at its headquarters in Fargo

Intertek Expands Pharmaceutical Services

Intertek announced an expansion of the pharmaceutical services for specialist inhalation and nasal product development for biologics in Melbourne near Cambridge

WuXi Biologics Announced Construction of a 69 million Integrated Manufacturing Center in Southwest China

WuXi Biologics commenced construction of a new million integrated manufacturing centre for innovative biologics at Chengdu Southwest China

Thermo Fisher Invests US$ 50 million to Expand Bioproduction Capabilities

Thermo Fisher Scientific announced that it is investing US million in its global bioproduction capabilities

Intertek to Expand Pharmaceutical Services Facility in Melbourn

Intertek announced the expansion of its pharmaceutical services laboratory in Melbourn near Cambridge through the acquisition of a new sq ft facility

Merck Announces Expansion of Manufacturing Facility with US$165 million investment

Merck announced an investment of US million in its manufacturing site at Aubonne Switzerland to expand its production of biotech medicines

MaSTherCell SA Announces New Manufacturing Facility in Belgium

MaSTherCell SA announced new manufacturing facility in Belgium for cell and gene therapy products The company has signed a lease agreement for a m ft facility located in Belgium The new facility will become a stateoftheart manufacturing and production site designed for latestage and commercially approved cell and gene therapy products

BioVectra Inc. Announces US$144.6 million Expansion

BioVectra Inc announced a fiveyear US million expansion project to enhance its Biopharmaceutical capabilities in Charlottetown Prince Edward Island and Windsor Nova Scotia

AirBridgeCargo - Air frieght solutions for your Pharma ACG - Myanmar Pharma Matcon Efficently handling tablets and powders in IBC's MECO - 90 Years